Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy

NCT04816916 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
12
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor is stopping the study to focus company resources on other development programs.

Conditions

Interventions

Sponsor

Axcella Health, Inc